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Abstract
Background: Recombinant antibodies are powerful tools in engineering of novel diagnostics. Due to the small size and
stable nature of llama antibody domains selected antibodies can serve as a detection reagent in multiplexed and sensitive
assays for M. tuberculosis.
Methodology/Principal Findings: Antibodies for Mycobacterium tuberculosis (M. tb) recognition were raised in Alpaca, and,
by phage display, recombinant variable domains of heavy-chain antibodies (VHH) binding to M. tuberculosis antigens were
isolated. Two phage display selection strategies were followed: one direct selection using semi-purified protein antigen, and
a depletion strategy with lysates, aiming to avoid cross-reaction to other mycobacteria. Both panning methods selected a
set of binders with widely differing complementarity determining regions. Selected recombinant VHHs were produced in E.
coli and shown to bind immobilized lysate in direct Enzymelinked Immunosorbent Assay (ELISA) tests and soluble antigen
by surface plasmon resonance (SPR) analysis. All tested VHHs were specific for tuberculosis-causing mycobacteria (M.
tuberculosis, M. bovis) and exclusively recognized an immunodominant 16 kDa heat shock protein (hsp). The highest affinity
VHH had a dissociation constant (KD) of 4610
210 M.
Conclusions/Significance: A broad set of different llama antibodies specific for 16 kDa heat shock protein of M. tuberculosis
is available. This protein is highly stable and abundant in M. tuberculosis. The VHH that detect this protein are applied in a
robust SPR sensor for identification of tuberculosis-causing mycobacteria.
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Introduction
For centuries,Tuberculosis (TB) hasbeena severehealthproblem
all over the world. Currently, it is estimated that the microbe
Mycobacterium tuberculosis causes 9.4 million new cases of TB each year
[1]. Recent and alarming developments around TB comprise the
appearance of multidrug-resistant strains and co-infection with HIV,
both of which reduce the lifetime of tuberculosis patients
significantly. Accurate and rapid diagnosis of active TB is essential
for both control of disease epidemic, and treatment of infected
patients. Current diagnostic methods for TB include DNA-based,
biochemical and serological approaches [2–6] but none of these
methods is yet appropriate for the high-throughput, rapid, reliable
and low-cost detection of TB in an affordable near-patient test.
Classical detection methods for infectious diseases such as TB
rely on rapid immunological detection. Use of recombinant
antibodies may facilitate multiplex design of protein chips, for
diagnosing several potential pathogens in parallel [7]. Further-
more, they can be deployed in novel bio-sensing systems such as
nanowires with very high sensitivity and potential for near patient
testing [8]. Llama antibody fragments (VHHs) are particularly
suited for these applications due to their compact size (15 kDa) [9]
and remarkable physicochemical stability [10–12]. Furthermore,
they were shown to display many additional advantages over other
recombinant antibodies, regarding cost of production, specificity,
affinity, and especially stability under conditions of diagnosis in the
field, which would make them suitable as detection units in
biosensors [13].
In the present study, our objective was to select and produce
VHHs capable of recognizing Mycobacterium tuberculosis antigens.
VHHs were selected by phage display from a library generated
from an immunized alpaca, and characterized. All characterized
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26754VHHs bound to the same target – the immunodominant 16 kDa
heat shock protein of M. tuberculosis - despite having highly diverse
sequence profiles. The utility of the selected VHHs in sensor
devices were demonstrated using a surface plasmon resonance
set-up.
Results
Generation of recombinant antibodies
Recombinant antibodies for M. tuberculosis detection were
obtained by phage display. A VHH phage display library with
10
7 clones was constructed from the lymphocyte RNA of an
alpaca immunized with M. tuberculosis lysate. This library was
subjected to two different methods of phage display selection: The
first method deployed a direct selection on M. tuberculosis protein,
enriched for 24 kDa, 16 kDa and 70 kDa proteins (Fig. 1). The
second method used a depletion strategy, where non-specific
phages were removed using total protein of non-tuberculosis
mycobacteria, and positive binders were selected on lysate of M.
tuberculosis. Both selection methods were carried out for three
selection rounds. After the last selection, VHH-encoding DNA
inserts from both selection methods were mass-excised and
transferred into an expression vector.
For each selection method DNA sequences of 96 clones were
analyzed. Ninety two of the 192 sequences were rejected because
they suffered from premature stop codons or the technical quality
of the sequencing reactions was poor. After removal of redundant
sequences, 62 unique protein sequences remained, which are
shown in Figure 2.
Based on protein similarity, VHH sequences could be clustered
into 6 groups (A, B, C, D, E and F) consisting of 29, 8, 6, 5, 2 and 3
members respectively (Fig. 2), while 9 sequences could not be
grouped. Both panning methods raised antibodies belonging to the
groups A, B and D, suggesting the presence of a dominant antigen
either during alpaca immunization or in vitro selection. Grouping
was mainly based on the antigen binding regions (CDRs), where
most sequence variation occurs. The length of the CDR3 region
represents the dominant difference between all single sequences
and sequence groups, ranging from five residues in group A to 27
residues in sequence B-B2 (Fig. 2). The variations in protein
sequence and length of the antigen binding regions suggests that
proteins from different origins with a broad range of sequence
diversity were selected.
Sequence groups were inspected for amino-acid substitutions
which could classify them as VHHs, and distinguish them from
canonical antibodies with heavy and light chain. Most of these
substitutions (at positions 42, 49, 50 and 52: underlined in Fig. 2)
could be regarded as adaptations to the absence of a light chain
[14,15] resulting in a more soluble VHH fragment. Most
prominently, the hydrophobic leucine at position 50 has changed
to a water-soluble arginine in 87% of the inspected sequences.
Other typical VHH substitutions occur at a lower frequency (15%
V42RF; 64% V42RY; 50% G49RE; 1.6% L50RC; 63%
W52RL and 1.6% W52RG).
Specificity of the selected antibodies
To characterize their properties into more detail, 12 clones (A-
23, A-28, A-44, A-50, A-89, A-93, B-A1, B-B12, B-D8, B-D10, B-
F9 and B-F10), representing the 6 groups and 3 single sequences,
were expressed in E. coli at 1 liter scale. Reactivity to M. tuberculosis
protein - already used for coating in phage display - was assessed in
a direct ELISA. All tested VHHs reacted with M. tuberculosis
protein, but not with E. coli protein (not shown), indicating that the
selected antibodies could specifically recognize M. tuberculosis. The
four clones with highest binding capability in ELISA (A-23, A-44,
A-50 and B-F10) were used for further analysis.
To investigate the capability of the VHH antibody fragments to
distinguish M. tuberculosis from other mycobacteria, further direct
ELISA experiments were carried out. For this purpose different
lysates of Mycobacterium tuberculosis substrains as well as other
Mycobacterium species and respiratory pathogens were tested. VHH
antibody fragments reacted well with all M. tuberculosis substrains
and M. bcg in different intensities, but not with M. avium, M.
kanssasi, M. smegmatis, S. pneumoniae and H. influenzae (Fig. 3B). Thus,
the selected antibodies displayed selectivity for M. tuberculosis.
Characterization of VHH antibody
The subcellular localization of the antigen recognized by the
four selected VHHs (A-23, A-44, A-50 and B-F10) was further
investigated. To this end, M. tuberculosis whole cells, M. tuberculosis
cell lysate and the media in which M. tuberculosis bacteria had
grown was tested in direct ELISA. In all experiments signal was
calibrated with those of the media (Middlebrook 7H9) or the
buffer (phosphate-buffered saline). It appeared that the VHHs
bind most strongly to the M. tuberculosis protein lysate (Fig. 3A),
indicating that they recognize an intracellular antigen.
To identify the target protein of the four selected VHH
antibody fragments, Western blot analysis of M. tuberculosis lysate
was carried out. As exemplified in Figure 4A for VHH A-23, all
four tested clones (A-23, A-44, A-50 and B-F10) showed binding to
a protein of 16 kDa size. Testing of a number of other selected
VHH antibodies (A-28, A-89, A-93, B-A1, B-B12, B-D8, B-D10
Figure 1. Whole and enriched protein lysate of M. tuberculosis.
Lysate enriched for 24 kDa, 16 kDa and 70 kDa M. tuberculosis protein
(lane 1) and whole M. tuberculosis lysate (lane 2). Shown is a 15% SDS
PAGE gel, stained by SYPRO ruby. Indicated are the positions of relevant
size markers in kDa.
doi:10.1371/journal.pone.0026754.g001
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not shown).
A 16 kDa heat shock protein of M. tuberculosis has been reported
before to represent an immunodominant protein and its gene was
cloned [16–20]. To confirm that the band on the western blot
corresponded to the 16 kDa hsp reported in the literature, two
experiments were performed. Firstly a Western blot analysis was
performed, testing the VHH A-23 side-by-side to the mouse
monoclonal antibody MoAb F24, which specifically recognizes the
16 kDa hsp [21]. Both tested antibodies bound an identical
pattern of bands with a major band around 16 kDa (Fig. 4B, lane
1 and 2). Secondly, the gene encoding the 16 kDa hsp of M.
tuberculosis was cloned and expressed in E .coli. Purified 16 kDa
heat shock protein of E. coli was analyzed by Western blotting.
VHH A-23 showed reactivity to the recombinant 16 kDa hsp
(Fig. 4B, lane 3). Similar results were obtained for the other VHHs
tested (A-28, A-89, A-93, B-A1, B-B12, B-D8, B-D10 and B-F9).
Both tests confirm that the 16 kDa hsp from M. tuberculosis is the
antigen recognized by these VHHs. When, prior to western blot,
antigen preparations were not subjected to denaturing, the
reactivity of the antigen was not altered (Fig. 4C).
The ability of the VHHs to recognize soluble antigen in a
biosensor set up was tested in a surface plasmon resonance
analysis. VHH A-23 was immobilized at 3818 RU in Fc4 on a
CM5 sensor chip. As a reference, VHH M200, selected for
recognition of Foot-and-mouth disease (FMD) [22], was used for
Figure 2. M. tuberculosis binding VHH antibody fragments. Protein sequence of 62 selected VHH antibody fragments selected by phage
display for binging to M. tuberculosis. Dots indicate sequence identity, and dashes indicate gaps. The three complementarity determining regions
CDR1, CDR2 and CDR3 are shaded. Characteristic VH-VHH hallmark substitutions (Leu12Ser, Val42Phe or Val42Tyr, Gly49Glu, Leu50Arg or Leu50Cys
and Trp52Gly or Trp52Leu (the last substitution is less well conserved) (the ImMunoGeneTics system [52] was followed) [15] are underlined. The 12
clones selected for further investigations are underlined. VHH protein sequences labeled A-x (with x=1–96) resulted from direct selection using semi-
purified protein antigen, protein sequences labeled B-yx (with y=A–F and x=1–12) were achieved by depletion method.
doi:10.1371/journal.pone.0026754.g002
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tions of Mycobacterium lysates (M. tb1, M. tb27 and M. smeg) were run
over both flow cells. M. tb 1 and M. tb27 bound to VHH A-23 on
the CM5 sensor chip, whereas it did not bind to the reference Fc3
(not shown). Lysate of M. smeg showed neither binding to VHH A-
23 nor to VHH M200. These results are in agreement with the
results obtained by ELISA and demonstrate that VHH A-23 is
capable of specifically binding the soluble M. tuberculosis antigen
(Fig. 5A, shown for M. tb1 and M. smeg).
The reproducibility of antigen detection by the A-23 biosensor
was investigated using whole M. tuberculosis lysate M. tb1. The
lysate was injected at highest concentration following approxi-
mately 8 cycles of antigen binding and regeneration. The maximal
RU signals were constant over 31 cycles with a mean of 23462
suggesting that regeneration conditions (10 mM HCl) do not affect
the quality of the immobilized VHH (Fig. 5B). The binding
between purified recombinant hsp and a selection of VHH (A-23,
A-44, A-50, A-89, B-A1, B-B12, B-D8, B-D10, B-F9 and B-F10)
was investigated. Among these, the binding by A-23, A-50, A-44
and B-F10 was found to be the strongest, and binding constants
were determined for these VHH. The KD value of B-F10 was
found to be best (4610
210 M), while A-23, A-50 and A-44 had
slightly lower affinities (2.4610
29 M, 2.2610
29 M and 3.76
10
29 M, respectively).
To quantify the antigen present in M. tuberculsosis lysates,
different concentrations of recombinant 16 kDa antigen (24 ng/
mL to 50 mg/mL) were injected for calibration. By plotting the
lower concentrations of 16 kDa antigen against the responses in
the biosensor, a linear calibration curve was obtained from a level
above the limit of detection of 24 ng/mL (Fig. 5C). The signal in
the VHH coated flow cell was almost linear up to the
concentration of 780 ng/mL and an RU of 119.5. At higher
concentrations the response leveled off. For accuracy, only values
below 120 RU were used to calculate the % of antigen in the
lysate. From the obtained calibration curve, the amount of antigen
in the whole protein content of the lysate was determined to be
6.660.6% in M. tb1 and 11.760.4% in M. tb27 whereas M. smeg
contained 0% of the 16 kDa antigen.
Discussion
The present study describes the successful selection of
recombinant VHHs specific for Mycobacterium tuberculosis. A panel
of recombinant antibodies was selected, which distinguish a
Figure 3. Direct ELISA to confirm specific binging of VHH antibody fragments to tuberculosis lysate. VHH antibody fragments A-23 and
B-F10 with A) M. tuberculosis whole cells, M. tuberculosis cell lysate and media in which M. tuberculosis bacteria were grown. B) different M. tuberculosis
lysates as well as lysates of M. bcg, M. avium, M. kansasii, M. smegmatis, S. pneumoniae and H. influenzae. Measurements were performed in duplicate,
expressed as means 6 SD.
doi:10.1371/journal.pone.0026754.g003
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teria. One of the selected VHH molecules was successfully
incorporated into an SPR-biosensor to detect and identify M.
tuberculosis. To our knowledge this is the first description of
recombinant llama antibody fragments specific for infectious M.
tuberculosis.
Two different phage display selection methods were used, one
by depletion of the library from non-tuberculosis lysates, and
another by using a partially purified protein preparation. The
depletion method aimed to select highly specific M. tuberculosis
VHH antibody fragments against potentially a very wide range of
antigens from the lysate, whereas the direct panning method
aimed to select VHH antibody fragments specific for the three
dominant proteins in the sample. We expected a large sequence
variety, and indeed, a broad spectrum of 68 unique sequences was
obtained. Out of which six sequences were found to be the same
from both selection methods, suggesting that both procedures
overlapped in their selectivity for an epitope. Investigations by
ELISA with a range of different mycobacteria revealed that the
selected llama antibody fragments allowed specific detection of all
tested tuberculosis-causing species, and distinguish them from non-
infectious mycobacteria such as M. kansasii, M. avium and M.
smegmatis and other respiratory pathogens such as S. pneumoniae, and
H. influenzae (Fig. 3B). Apparently, both selection methods lead to
antibodies that specifically recognize the Mycobacterium tuberculosis
complex.
Earlier, selection of several mouse single-chain fragments (scFvs)
reactive with M. tuberculosis culture proteins by phage display was
reported [23], and very recently also chicken scFv antibodies for
16 kDa hsp [24]. In the present work, VHH was preferred over
scFv, because scFvs are larger, and often suffer from poor stability,
unless genetically engineered [25,26], while VHHs often display
high stability over long periods of exposure to ambient
temperature [10], which allowed for extensive re-use of the SPR
chip.
Surprisingly, Western blot analysis showed that all 12 tested
VHHs from different clusters bind to the species-specific 16 kDa
hsp (Fig. 4B), despite the high sequence diversity among the
clusters (Fig. 2). Apparently also in alpaca the 16 kDa hsp behaves
as an immunodominant antigen, and possibly there are several
different epitopes. The specificity for the 16 kDa hsp is consistent
with studies into the conservation of this protein among
mycobacteria. Southern blot analysis of genomic DNA of several
mycobacteria, using the coding sequence of the 16 kDa hsp gene
as a probe [27], showed the absence of a homologue of the 16 kDa
hsp in non-tuberculosis species. Only the tuberculosis related M.
bovis bacillus Calmette-Gue ´rin (BCG) strain showed a specific
hybridization, which is in agreement with our observation that
16 kDa hsp specific VHHs (A-23, A-44, A-50 and B-F10) showed
binding to M. tuberculosis and M. bovis BCG but not to any other
tested Mycobacterium species in ELISA (Fig. 3B). Similar results
were observed by Coates et al for the mouse monoclonal antibody
[28] TB68, which binds to the 16 kDa hsp of all tested strains of
M. tuberculosis and M. bovis species [29].
The 16 kDa hsp is known under several names (Hsp16.3,
sHsp16 and Acr) [30] and shares a low sequence homology with
the a-crystallin-related small heat shock protein family [31]. It has
been suggested that this antigen acts in vitro as an adenosine
triphosphate-independent chaperone and may occur as a
dodecamer, or as monomers [17,32]. The form of antigen that
is recognized by the VHH is probably the monomeric structure.
The hsp was isolated from bacteria by a denaturing treatment,
which would cause monomer formation, and reactivity of the
antigen is not very different after western blotting from a native gel
or a denaturing gel (Fig. 4). Also heat denaturing of antigen hsp
did not change its mobility in native gels (not shown). Thus,
probably the antigen is recognized in monomeric form, while we
have no dodecameric form available for testing its reactivity.
Several murine monoclonal antibodies against the prominent
hsp antigen of M. tuberculosis have been selected in the past
[21,29,33]. It has been subcloned, overexpressed and purified
[17,20]. The results of the SPR experiments comparing the
Mycobacterium lysates to purified recombinant 16 kDa hsp show
that 7 to 12% of cellular protein consists of 16 kDa hsp. This
would correspond to 66 million copies of 16 kDa hsp per cell,
taking into account its molecular weight, and an estimated 160 fg
total protein per cell [34]. The concentration of hsp in the total
protein content of M. tb is comparable with Lipoarabinomannan
(LAM), the major glycolipid of the outer cell wall which may
represent up to 15% of the total bacterial weight [35] and is used
for tuberculosis detection in urine samples [36]. Due to its rich
presence in bacteria lysate, the highly expressed 16 kDa hsp seems
to be a relevant biological target for TB diagnostic assays [34].
Nevertheless it may be worthwhile to develop stable and high
affinity VHH antibodies to secreted M. tb proteins such as the
24 kDa protein [37] for diagnosis.
The 16 kDa hsp is a cytosolic protein, as hardly any ELISA
signal of the VHHs to whole cells or culture medium of the M.
tuberculosis cultures could be observed, while a strong signal
occurred in the cell lysate (Fig. 3A). These observations are in
agreement to reports of others, who report that the 16 kDa hsp is
not released into the culture supernatant [38,39], but is
peripherally associated with the membrane [40]. One conse-
quence of this subcellular localization is that lysis of bacteria will be
necessary before detection in sputum. One might argue that a
Figure 4. Western blot to discover antigen of VHHs. A) Western
blot using VHH A-23 as a probe. 9 mg M. tb 1 lysate were run on a 15%
SDS-PAGE gel in lanes A–D, and transferred to a nitrocellulose
membrane. Lane A: incubated with VHH A-23 and detected using
anti-VSV-HRP; Lane B: incubated with VHH A-23 and detected using
anti-HIS-HRP; Lane C: incubated with detection antibody anti-VSV-HRP;
Lane D: incubated with detection antibody anti-HIS-HRP. B) Western
blot analysis to confirm the specificity of VHH A-23. Lane 1: 9 mg M. tb
22 lysate detected by monoclonal mouse 16 kDa antibody, using anti-
mouse-HRP secondary antibody; Lane 2: 9 mg M. tb 22 lysate detected
by VHH A-23, using anti-VSV-HRP secondary antibody. Lane 3: 3 mgo f
purified recombinant 16 kDa protein detected by VHH A-23, using anti-
VSV-HRP secondary antibody. Due to the tags added for purification
and detection purposes the calculated mass of the recombinant 16 kDa
protein is 21 kDa. Indicated are the positions of relevant size markers in
kDa. C) Western blot analysis of native PAGE analysis. Lane 1: 5 mg M. tb
27 lysate; Lane 2: 1 mg of purified recombinant 16 kDa protein.
Detection was by VHH A-23, using anti-VSV-HRP secondary antibody.
doi:10.1371/journal.pone.0026754.g004
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PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26754Figure 5. Surface plasmon resonance analysis to show specific binding of VHHs to soluble antigen. A–C) VHH A-23 immobilized at 3818
RU on a CM5 sensor chip in Fc4 and VHH M200 [22] immobilized at 3851 RU in the reference channel Fc3. Sensorgrams were corrected by subtracting
the signal from the reference flow channel Fc3. A) Sensorgrams obtained after injection of M. tuberculosis (left) and M. smegmatis (right) lysate. 50 mL
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convenient for immunological detection. On the other hand, most
tuberculosis-detection methods based on nucleic-acid amplifica-
tion also require vigorous disruption of sputum and mycobacterial
cells and a secreted antigen may be too dilute in sputum [41].
Most serological tests for tuberculosis screen for reactivity in the
patient’s serum to specific M. tuberculosis antigens, such as the
16 kDa hsp [20,42,43]. However, such serum-reactivity tests have
limited value, as antibodies remain present after BCG vaccination,
after successful treatment of the infection and during latent
infection, which complicates the diagnosis of active TB disease.
Therefore, more efforts have been directed towards direct
detection of M. tuberculosis antigens in sputum, serum, urine and
cerebrospinal fluid of patients, and there VHH antibodies against
the 16 kDa hsp may represent a useful tool for the development of
diagnostic tests.
An SPR biosensor using one of the selected VHHs allowed
detection of recombinantly produced 16 kDa hsp antigen of M.
tuberculosis. Moreover, the SPR sensor was able to positively
identify crude lysates of M. tuberculosis, enabling the specific
detection of tuberculosis-causing infectious agent. The sensor
system proved to provide reproducible results after a significant
number of regenerations, which is an important attribute for a
sensing device. Importantly, further experiments should prove the
value of an SPR sensor in the identification of M. tuberculosis in
patients’ material. At its current sensitivity (24 ng of 16 kDa hsp
per mL; Fig. 5C), the limit of detection would be about 10
6 cells
per mL, when taking into account that 16 kDa makes up
approximately 10% of total Mycobacterium protein and a cellular
protein content of 150 fg/cell [34]. The current limit of detection
using microscopy is around 10,000 cells per mL.
Sensitivity of the SPR system could be greatly enhanced by
immobilization of VHHs in an oriented way, leading to increased
exposure of antigen-binding sites. Such orientation of antibodies
like VHH could be achieved by site-specific biotinylation of the
VHH, or other, covalent immobilization methods [44]. SPR
results indicated a dissociation constant of 4610
210 M for B-F10.
Whereas other VHH with 10-fold higher affinity have also been
reported [45] [45], affinity maturation of the VHH by rounds of
mutagenesis and selection could significantly improve the affinity
of the antigen, and thereby the sensitivity of the sensor [46] and
finally multivalent and multispecific VHHs could be engineered
for strongly enhanced affinity for the antigen. VHHs against a
broad range of antigen targets could be selected by tuning the
phage display selection method and the specificity and sensitivity
of M. tb detection could be greatly enhanced by the combination of
VHHs for rapid, near patient multiplexing in the near future.
SPR is one of the more established biosensor principles. Other
methodologies, such as piezoelectronic immunosensors or fluores-
cent nanoparticles coupled with flow cytometry, and nanowires
are further away from application in practice [8,47,48]. Still, SPR
equipment is hardly compatible with field settings in countries
where tuberculosis diagnosis is needed most. Recent efforts to
implement portable SPR devices in tuberculosis diagnostics [49]
may contribute to the solution of this problem.
Materials and Methods
Bacteria samples
All mycobacteria (Royal Tropical Institute, Amsterdam, The
Netherlands) were grown in Middlebrook 7H9 medium (Difco,
BD, Sparks, MD, USA) supplemented with 10% OADC (BBL,
BD) until mid-log phase and heat-killed at 80uC for 20 min. Other
respiratory pathogens (Streptococcus pneumoniae D39 and nontypable
Haemophilus influenzae R2866 [Radboud University Nijmegen
Medical Center CUKZ, Nijmegen, The Netherlands]) were
grown on chocolate agar. Heat-inactivated bacteria were used as
‘whole cells’ to test binding of antibodies to surface proteins. To
obtain the lysate of Mycobacterium as antigen source, bacteria were
centrifuged at 13,000 g for 5 min after heat killing. After 2
washing steps with phosphate-buffered saline (PBS) to remove all
media the bacteria pellet was resuspended in PBS. 500 mLo f
bacterial suspension was lysed with 0.6 g zirkonia/silica 0.1 mm
(BioSpec Products Inc, Bartlesville, OK, USA) in a Retch MM
301 (Retch GmbH, Germany) for 15 min at 30 hertz. To remove
soluble particles, the lysate was centrifuged for 5 min at 13,000 g.
The obtained supernatant was used as cell lysate. Protein
concentration of mycobacterium samples were determined with
the Pierce 660 nm Protein assay using Nanodrop and albumin as
reference protein for the standard curve.
To obtain enriched lysate 2 mL of centrifuged M. tb lysate was
brought into 20 mM ethanolamine (pH 9.0) and loaded on a
1 mL HiTrap MonoQ column (Pharmacia). After washing
extensively with 20 mM ethanolamine (pH 9.0), a linear gradient
from 0 to 1 M NaCl in 20 mM ethanolamine (pH 9.0) was
applied, and 1 mL fractions were collected. Around 0.4 mM
NaCl, a fraction eluted in which proteins of 16 kDa, 24 kDa and
63 kDa were overrepresented, and this fraction was used for
subsequent selections.
Library construction
A VHH library was formed from lymphocyte RNA from a 3-
year old female alpaca (GDL, Utrecht University, The Nether-
lands) as previously described [10]. Experiments with alpacas were
approved by the Dutch Animal Ethical Commission (Dier
Experimenten Commissie, DEC; permit 06/284) of the Utrecht
University, following the Dutch Law on animal experiments (‘‘Wet
op de Dierproeven’’ : http://wetten.overheid.nl/BWBR0003081/
geldigheidsdatum_05-09-2011). 100 mgo fM. tuberculosis lysate was
used for the immunization. VHHs were amplified from first-strand
cDNA with VHH specific primers lam07, lam08 and lam17 [50].
Amplified fragments were pooled and ligated into the pHEN2
phagemid vector [51] in frame with the M13 gene 3 for expression
of VHH-g3p fusion protein. Electroporation of recombinant
plasmid into competent Escherichia coli TG1 cells resulted in about
lysate at concentration of 3.8 (lowest), 7.5, 15, 30 and 60 (highest) mg/mL were injected at a constant flow (10 mL/min.). B) Sensorgrams obtained after
repeated injection of M. tuberculosis lysate. 50 mL lysate at concentration of 60 mg/mL were repeatedly injected at a constant flow (10 mL/min.).
Sensor was regenerated with 5 mL of a 10 mM HCl solution at 10 mL/min after each run. C) Left: Sensorgrams achieved after injection of purified
recombinant 16 kDa antigen. 50 mL lysate at concentration of 24 (lowest), 49, 98, 185, 391, 781, 1.6610
3, 3.1610
3, 6.3610
3, 12.5610
3,2 5 610
3 and
50610
3 (highest) ng/mL were injected at a constant flow (10 mL/min.). Right: Calibration curve of purified recombinant 16 kDa antigen as obtained
by BIAevaluation using the 4 parameter fit. D) Sensorgrams achieved after injection of VHH A-23. Purified recombinant 16 kDa antigen was
immobilized at 4100 RU on a CM5 sensor chip in Fc2 and inactivated Fc1 was used as reference. 100 mL VHH at concentration of 0.025 (lowest), 0.05,
0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.3 and 12.5 (highest) mg/mL were injected at a constant flow (50 mL/min.). Sensorgrams were corrected by subtracting the
signal from the reference flow channel Fc1. To obtain the dissociation equilibrium constant (KD) the sensorgrams were fitted by a global Langmuir 1:1
model (BIAevaluation software) using the six lowest VHH concentrations.
doi:10.1371/journal.pone.0026754.g005
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7 individual recombinants. Phage particles were produced in E.
coli as described earlier [10].
Selection
The library containing approximately 10
7 individual clones was
panned separately using two different panning strategies.
Direct Panning Method
The first selection was carried out by panning of the VHH-
displayed phage library directly against the M. tuberculosis lysate,
enriched for 24 kDa protein, 16 kDa protein and another high-
molecular weight protein around 70 kDa (Fig. 1). Wells of
microtiter ELISA plates (GreinerBioOne, The Netherlands) were
coated with 100 mL lysate (10 mgm L
21 in 0.1 M Sodium
Carbonate Solution pH 9.6) overnight at 4uC. Plates were emptied
the next day and washed 1 time with 200 mL PBS and unspecific
binding sites were blocked for 1 h with 250 mL PBS containing 2%
(w/v) nonfat powdered milk (2% PBSM). 100 mL phages
(10
11 cfu mL
21) were blocked for 30 min with 50 mL PBS
containing 10% nonfat powdered milk (w/v) (10% PBSM) before
100 mL of this mix was applied to the wells and incubated for 1 h
on a shaker. Excess phages were washed away with 5 washes of
200 mL 0.05% Tween-20 in PBS (0.05% PBST) and 5 washes of
200 mL PBS. Phages from the Mycobacterium selection were eluted
with 100 mL of 0.1% trypsin in PBS for 15 min. Eluted phages
were then used to infect E. coli TG-1 cells. The phage populations
were amplified and rescued by VCSM13 helper phage to generate
phage displaying VHH to be used for the next round of panning.
To raise the selection stringency, the number of washing steps
before trypsin elution was increased by 5 after each panning
round. After three rounds of panning, the in- and output were
titrated to monitor the success of the selection.
Depletion Panning Method
Targets were immobilized overnight at 4uC in microtiter ELISA
plate wells (GreinerBioOne, The Netherlands) using the following
conditions: 6 wells were coated with 100 mL Mycobacterium mix
(lysate of M. kansasii, M. avium, M. fortuitum and M. chelonae,
3 mgm L
21) in PBS and one well with 100 mL lysate of M.
tuberculosis (3 mgm L
21) in PBS. The next day, plates were emptied
and washed one time with 200 mL PBS and blocked for 1 h with
250 mL 2% PBSM. 300 mL phages (10
11 cfu mL
21) were blocked
for 30 min with 100 mL 10% PBSM before 100 mL of this mix
were applied to the emptied lysate-containing (Mycobacterium mix)
well and incubated for 15 min on a microtiter plate shaker. The
supernatant was then transferred to the next lysate-containing
(Mycobacterium mix) well and incubated for 15 min under shaking.
This procedure was repeated for the remaining 4 wells coated with
the Mycobacterium mix lysate. Finally the supernatant was
transferred to the well coated with M. tuberculosis lysate and
incubated for 30 min on the shaker. Excess phages were washed
away with 5 washes of 200 mL 0.05% PBST and 5 washes of
200 mL PBS. Phages from the Mycobacterium selection were eluted
with 100 mL of 0.1% trypsin in PBS for 15 min. Eluted phages
were then amplified, rescued and re-used. In additional panning
rounds stringency was increased by increasing the number of
washing steps by 5 after each panning round.
Recloning of selected VHHs for expression
For both panning methods, plasmids from selected phage pools
were extracted using QIAprep Spin Miniprep Kit (250) (QIA-
GEN, The Netherlands). DNA was cut using the unique PstI and
NotI restriction sites and then purified using the Jetquick gel
extraction kit (Genomed, Germany). VHH sequences were then
bulk-ligated into a PstI and NotI digested PRI-VSV expression
vector, a strong expression vector for expression in the periplasm,
based on the backbone of the pRSET-A vector (Invitrogen, The
Netherlands). Expression of the recombinant VHH was under
control of the T7 promoter. The C-terminus of the VHH was
fused to a VSV-tag (YTDIEMNRLGK) for detection purposes
along with a 66 His tag for purification purposes followed by a
stop codon. For cloning purposes a NotI restriction site was
introduced between the VHH and the VSV-tag.
Constructs were introduced into E. coli XL-1 blue. 96 randomly
picked colonies were used for colony PCR with the primer T7 (59-
TAATACGACTCACTATAGG -39) and AS2 (59- GCTAGT-
TATTGCTCAGCGG -39). Sequencing of 96 colonies from the
first panning method resulted in 34 unique VHH protein
sequences (labeled A-x, with x=1–96), for the depletion method
in 34 unique full length protein sequences (labeled B-yx, with
y=A-F and x=1–12). All duplicate sequences were omitted. The
remaining 62 non-redundant VHH sequences were aligned
according to ImMunoGeneTics system [52] for immunoglobulins
and classified into different groups. As VHHs had unusual long
CDRs, additional gaps were introduced in the numbering at the
end of CDR1 and CDR2 and labeled with letters A and a to e,
respectively.
Sequences for 12 representatives which were used for further
analysis have been submitted to Genbank under accession
numbers JN234011–JN234022.
Expression and Purification of recombinant VHHs
Representative sequences from each panning method were
selected from different groups for expression in E. coli BL21-AI, a
strain which carries a chromosomal insertion of the T7 RNA
polymerase gene in the araB locus of the araBAD operon, allowing
the expression of recombinant VHH in the presence of L-
arabinose. Bacteria were induced to express the VHH and urea-
lysed as described previously [10] using PBS as buffer. VHHs were
purified using Ni-NTA Superflow resin (QIAGEN, Germany) as
reported before [10]. Eluates were dialyzed against 8 liter of PBS
in two steps after Ni-NTA metal-affinity chromatography and
samples were stored in 1.5 mL batches containing a final
concentration of 15% glycerol at 220uC. Protein concentration
was determined using Bradford test [53] while successful
expression and purification was verified on a 15% sodium
dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE)
gel. As previously shown by Beekwilder et al. [10] the expressed
VHHs were the dominant proteins in the E. coli cell pellets (data
not shown).
Direct ELISA
Wells of flat-bottom ELISA plates (medium-binding, Greiner-
BioOne, The Netherlands) were coated with 2 mgm L
21 lysate of
Mycobacterium species or other respiratory pathogens (S. pneumoniae
and H. influenza) in PBS and incubated at 4uC overnight. Antigen-
coated wells were emptied and washed one time with 200 mL PBS
and then blocked with 150 mL PBS containing 4% nonfat
powdered milk (w/v) (4% PBSM) for 1 h at room temperature.
Wells were emptied and 100 mL VHH (0.5 mg mL
21)i n2 %
PBSM was added and binding was allowed to occur for 1 h.
Excess VHHs were removed by washing three times with 200 mL
PBST, and anti-VSV-HRP conjugate (Sigma Aldrich, Missouri,
USA) was added at a 1:2000 dilution for 1 h in 2% PBSM. Excess
conjugate was washed off three times with 200 mL PBST and three
times with 200 mL PBS. Subsequently HRP activity was
determined by adding 1-StepTM Ultra TMB-ELISA substrate
Llama Antibodies for Tuberculosis
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dark for 10 min and then stopped with 1 M sulphuric acid and the
OD was measured at 415 nm in a microtiter plate-reader
(TECAN SpectraFluor Microplate Reader).
Similar method was employed for direct ELISA of whole cells
and supernatant by using 100 mL for coating.
Western Blot analysis
Cell lysates containing approximately 9 mg total protein were
first boiled and reduced in buffer and electrophoresed on a 15%
SDS-PAGE gel and SYPRO ruby (Bio-Rad, Hercules, CA)
stained to ensure the full complement of proteins was resolved.
For Western blotting, proteins were transferred from an unstained
gel to nitrocellulose membranes (Trans-Blot, Bio-Rad, Hercules,
CA). Membranes were blocked overnight at room temperature in
4% PBSM on a shaker. The membrane was then incubated with
purified VHH (0.1 mg mL
21 in 2% PBSM) for 1 h at room
temperature on a shaker. Membranes were washed once in 2%
PBSM and three times in 0.1% PBST. Subsequently, membranes
were incubated with HRP-conjugated anti-VSV-tag antibodies
(1:2000 in 2% (w/v) PBSM, Sigma Aldrich, Missouri, USA) or
anti-HIS-tag (1:5000 in 2% (w/v) PBSM, Roche, Mannheim,
Germany) for 1 h at room temperature on a shaker. Membranes
were washed once with 2% PBSM followed by two washing steps
with TBS containing 0.1% Tween 20 and two washing steps with
TBS. Binding was detected with 3,3,5,59-Tetramethylbenzidine
(TMB) liquid substrate system for membranes (Sigma-Aldrich,
The Netherlands). Molecular weight standard was Precision Plus
Kaleidoscope (BioRad, Hercules, CA).
Recombinant 16 kDa protein
The 16 kDa protein was PCR-amplified from M. tuberculosis
lysate using the primer HSP16.3-PstI-FW (59- AAAAAAACTG-
CAGAAAATGGCCACCACCCTT CCC -39) and HSP16.3-
NotI-RV (59- AAAAAAAAGCGGCCGCGTTGG TGGACCG-
GATCTGAA -39)( PstI and NotI restriction sites are underlined).
The digested fragment was inserted in a PstI-NotI cut PRI-AVI
expression vector. This vector is similar to the earlier described
PRI-VSV expression vector, but the C-terminus of the protein is
fused to an AVI-tag
TM (Avidity, LLC, Denver, Colorado) and a
66His tag for purification purposes followed by a stop codon. The
construct was transformed into E. coli XL-1 blue for multiplication.
The cloned hsp sequence is identical to GenBank accession
number S79751. Isolated plasmid DNA was transformed into E.
coli strain BL21-AI for expression. Expression and Ni-NTA metal-
affinity chromatography purification was performed as described
for VHH. The calculated mass of the recombinant 16 kDa protein
was determined to be 21 kDa.
Surface Plasmon Resonance (SPR)
The Biacore 3000, carboxymethyl dextran sensor chips (CM5),
HBS-EP buffer (pH 7.4, consisting of 10 mM 4-(2-hydroxyethyl)-
piperazine-1-ethanesulfonic acid, 150 mM sodium chloride,
3 mM ethylenediaminetetraacetic acid, 0.005% v/v surfactant
polysorbate 20), the amine coupling kit (containing 0.1 M N-
hydroxysuccinimide (NHS), 0.4 M 1-ethyl-3-(3- dimethylamino-
propyl)carbodiimide hydrochloride (EDC) and 1 M ethanolamine
hydrochloride (pH 8.5)) were purchased from GE Healthcare
(Uppsala, Sweden).
Selected VHHs were immobilized onto a CM5 surface by the
use of the amine coupling kit and the Surface Preparation Wizard
as present in the Biacore 3000 control software. The biosensor
surface was activated by injecting (35 mL at a flow rate of 5 mL/
min) a mixture of EDC and NHS (1:1; v/v) into one of the four
flow channels (Fcs). Then VHH (50 mg/mL diluted in coupling
buffer (10 mM sodium acetate, pH 4.0)) was injected and bound
to the activated carboxymethylated dextran surface via its primary
amine groups, aiming for an immobilization level of 5000 response
units (RU). After coupling, the remaining active groups were
blocked with ethanolamine hydrochloride (1 M).
In the experimental set-up, a reference (non-tuberculosis
binding, M200 [22]) VHH was immobilized in the reference
Fc3 and the tuberculosis specific VHH was immobilized in Fc4,
both with a final response of approximately 3800 RU. The Biacore
3000 operated at a constant temperature of 25uC and a constant
flow of 10 mL/min. 50 mL Mycobacterium lysates in HBS-EP buffer,
each of different concentration, were injected over the two serially
connected Fcs. Regeneration of sensor surface was done with 5 mL
of a 10 mM hydrogen chloride (HCl) solution at 10 mL/min after
each run. For quantitative analysis, a calibration graph was
prepared by using different concentrations of purified 16 kDa
antigen in HBS-EP. All sensorgrams were referenced by
subtracting the signal from the reference flow channel (Fc3) from
Fc4 and were evaluated using the BIAevaluation software.
To check the affinity of different representative VHHs (A-23, A-
44, A-50, A-89, B-A1, B-B12, B-D8, B-D10, B-F9 and B-F10)
against the 16 kDa hsp, the antigen was immobilized at 4100 RU
on a CM5 sensorchip in Fc2 using the amine coupling method. A
second flow cell (Fc1) was treated with the same chemical
procedure without antigen and used as a reference. At a constant
flow rate of 50 mL/min different concentrations of 100 mL VHH
ranging from 12.5 to 0.025 mg/mL in HBS-EP were injected 120 s
over the two flow cells and followed by a dissociation step of 400 s.
The sensor surface was regenerated with 25 mL of a 20 mM HCl
solution. The resulting sensorgrams were referenced by subtract-
ing the signal from the reference flow channel (Fc1) from Fc2. To
obtain the dissociation equilibrium constant (KD) the sensorgrams
were fitted by a global Langmuir 1:1 model (BIAevaluation
software) using the six lowest VHH concentrations.
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